Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

May 9, 1997

Cinchonine shown to reverse multidrug resistance

May 9, 1997

Preclinical and preliminary clinical data reported for LU-103793

May 9, 1997

Oxi-104 to enter clinic

May 8, 1997

Tumor regression reported for StressGen's stress gene therapy

May 8, 1997

Novel antitumor gene therapy under development at Oxford BioMedica

May 8, 1997

Highly effective anthrapyrazole described by Boehringer Mannheim and U. of Vermont

May 8, 1997

Phase I/II prostate cancer studies under way for DUROS leuprolide

May 7, 1997

BioChem Pharma's BCH-4556 to enter U.S. phase I trial in cancer

May 7, 1997

Cell Genesys files IND for cancer gene therapy

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...